Skip to content

Member

Roberta METSOLA

EPP · Malta

Group
EPP PPE
Country
Malta
Roll-call participation
0.0 %ⓘ of 5 928 roll calls in office · chamber median 90.2 % · whole term, roll calls No vote recorded while in office in this period (not the same as absent: chairing the sittings, as the President does, looks the same).
With majority line
no votesⓘ
More facts (4)
National party
PN Partit Nazzjonalista
In office
Since 16 Jul 2024
Against clear line
no votesⓘ
Member id
118859
More

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

No vote recorded while in office in this period (not the same as absent: chairing the sittings, as the President does, looks the same).

Roll-call participation ⓘ

0.0 %

0 of 5 928 roll calls while in office

Chamber median: 90.2 %

With majority line ⓘ

no votes

no votes where their group had a line in the period

Against clear line ⓘ

no votes

no votes where their group had a clear line in the period

Abstention ⓘ

no votes

no votes cast in the period

  • Whole term, 5 928 roll-call votes.
  • “No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
  • A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 5 928

Export

Every roll-call vote of the term with the member’s position, newest first.

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
DateDecision and voteResultPositionMajority line
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 46 — part 2 406 for, 214 against, 29 abstainedPosition: No vote recorded Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 46 — part 1 470 for, 117 against, 63 abstainedPosition: No vote recorded Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 45 — part 3 334 for, 270 against, 34 abstainedPosition: No vote recorded Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 45 — part 2 327 for, 272 against, 42 abstainedPosition: No vote recorded Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 45 — part 1 433 for, 153 against, 53 abstainedPosition: No vote recorded Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Separate vote on paragraph 44 349 for, 228 against, 79 abstainedPosition: No vote recorded Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 43 — part 2 340 for, 285 against, 24 abstainedPosition: No vote recorded Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 43 — part 1 358 for, 210 against, 81 abstainedPosition: No vote recorded Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Separate vote on paragraph 41 362 for, 214 against, 75 abstainedPosition: No vote recorded Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 24 — part 2 337 for, 303 against, 19 abstainedPosition: No vote recorded Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 24 — part 1 532 for, 42 against, 82 abstainedPosition: No vote recorded Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 21 — part 2 433 for, 135 against, 65 abstainedPosition: No vote recorded Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 21 — part 1 548 for, 37 against, 60 abstainedPosition: No vote recorded Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Amendment 8, adding text after paragraph 19 215 for, 294 against, 144 abstainedPosition: No vote recorded Majority line: Abstained
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Amendment 7, adding text after paragraph 19 278 for, 304 against, 69 abstainedPosition: No vote recorded Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 18 — part 3 399 for, 182 against, 72 abstainedPosition: No vote recorded Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 18 — part 2 299 for, 354 against, 6 abstainedPosition: No vote recorded Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 18 — part 1 435 for, 197 against, 22 abstainedPosition: No vote recorded Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 16 — part 4 353 for, 224 against, 63 abstainedPosition: No vote recorded Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 16 — part 3 330 for, 256 against, 57 abstainedPosition: No vote recorded Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 16 — part 2 339 for, 302 against, 12 abstainedPosition: No vote recorded Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 16 — part 1 539 for, 20 against, 88 abstainedPosition: No vote recorded Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 8 — part 3 388 for, 169 against, 88 abstainedPosition: No vote recorded Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 8 — part 2 472 for, 133 against, 45 abstainedPosition: No vote recorded Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 8 — part 1 501 for, 61 against, 74 abstainedPosition: No vote recorded Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Amendment 6, adding text after paragraph 6 194 for, 309 against, 145 abstainedPosition: No vote recorded Majority line: Abstained
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 6 — part 5 342 for, 280 against, 30 abstainedPosition: No vote recorded Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 6 — part 4 601 for, 46 against, 9 abstainedPosition: No vote recorded Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 3 — part 2 490 for, 141 against, 26 abstainedPosition: No vote recorded Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 3 — part 1 406 for, 200 against, 35 abstainedPosition: No vote recorded Majority line: For
16 Sept 2026An EU cardiovascular diseases strategy Final vote on the motion for a resolutionAdopted 545 for, 47 against, 75 abstainedPosition: No vote recorded Majority line: For
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Final vote — text as a wholeAdopted 470 for, 129 against, 62 abstainedPosition: No vote recorded Majority line: For
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 6, adding text after recital F 213 for, 426 against, 20 abstainedPosition: No vote recorded Majority line: Against
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 12, adding text after paragraph 64 218 for, 434 against, 4 abstainedPosition: No vote recorded Majority line: Against
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 11, adding text after paragraph 64 220 for, 432 against, 6 abstainedPosition: No vote recorded Majority line: Against
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 10, adding text after paragraph 64 175 for, 438 against, 50 abstainedPosition: No vote recorded Majority line: Against
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 9 to paragraph 64 205 for, 442 against, 10 abstainedPosition: No vote recorded Majority line: Against
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 8 to paragraph 56 216 for, 439 against, 8 abstainedPosition: No vote recorded Majority line: Against
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 7 to paragraph 35 231 for, 426 against, 9 abstainedPosition: No vote recorded Majority line: Against
16 Sept 2026Nuclear decommissioning assistance programme of the Ignalina nuclear power plant in Lithuania for the period 2028-2034 Final votePassed 625 for, 20 against, 22 abstainedPosition: No vote recorded Majority line: For
16 Sept 2026EU-Norway Agreement on the participation of Norway in GOVSATCOM and in the Union Secure Connectivity Programme Final vote on the draft Council decisionConsent given 612 for, 8 against, 16 abstainedPosition: No vote recorded Majority line: For
16 Sept 2026Instrument for Nuclear Safety Cooperation 2028-2034 Final votePassed 600 for, 21 against, 48 abstainedPosition: No vote recorded Majority line: For
16 Sept 2026EU-Iceland Agreement on the participation of Iceland in GOVSATCOM and in the Union Secure Connectivity Programme Final vote on the draft Council decisionConsent given 631 for, 7 against, 15 abstainedPosition: No vote recorded Majority line: For
16 Sept 2026EU-Switzerland Agreement on the transfer of passenger name record (PNR) data for the prevention, detection, investigation and prosecution of terrorist offences and serious crime Final vote on the draft Council decisionConsent given 549 for, 75 against, 30 abstainedPosition: No vote recorded Majority line: For
16 Sept 2026EU-UK Agreement regarding cooperation on the application of their respective competition laws Final vote on the draft Council decisionConsent given 640 for, 5 against, 26 abstainedPosition: No vote recorded Majority line: For
16 Sept 2026Establishing the Single Market and Customs Programme for the period 2028-2034 Final votePassed 496 for, 53 against, 125 abstainedPosition: No vote recorded Majority line: For
16 Sept 2026Establishing the Single Market and Customs Programme for the period 2028-2034 Amendment 86 to Article 9, paragraph 2 131 for, 532 against, 10 abstainedPosition: No vote recorded Majority line: Against
16 Sept 2026Establishing the Single Market and Customs Programme for the period 2028-2034 Amendment 85, adding text after Article 8 138 for, 532 against, 4 abstainedPosition: No vote recorded Majority line: Against
16 Sept 2026Establishing the Single Market and Customs Programme for the period 2028-2034 Amendment 84 to Article 4, after paragraph 1 168 for, 505 against, 4 abstainedPosition: No vote recorded Majority line: Against
16 Sept 2026Defence readiness and facilitating defence investments and conditions for the defence industry (Omnibus V) Final vote on the provisional agreementPassed 530 for, 125 against, 12 abstainedPosition: No vote recorded Majority line: For

Show all 50 votes on this page

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 107 of 107 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table
Roll calls held at each sitting while in office and how many of them the member voted in.
SittingRoll callsVoted in
17 Jul 2024230
18 Jul 202410
16 Sept 202420
18 Sept 202420
19 Sept 2024920
7 Oct 202420
8 Oct 202410
9 Oct 2024180
10 Oct 202440
21 Oct 202420
22 Oct 2024100
23 Oct 20241290
24 Oct 2024130
13 Nov 202420
14 Nov 2024360
25 Nov 202420
26 Nov 2024180
27 Nov 2024110
28 Nov 2024570
17 Dec 2024130
18 Dec 2024330
19 Dec 2024450
20 Jan 202520
21 Jan 202510
22 Jan 202520
23 Jan 2025450
10 Feb 202510
11 Feb 2025320
12 Feb 2025100
13 Feb 2025300
10 Mar 202520
11 Mar 202590
12 Mar 20252280
13 Mar 2025240
31 Mar 202530
1 Apr 2025350
2 Apr 20252510
3 Apr 2025620
5 May 202550
6 May 2025100
7 May 20252200
8 May 20251030
21 May 202520
22 May 2025530
16 Jun 202520
17 Jun 2025410
18 Jun 2025910
19 Jun 2025870
7 Jul 202510
8 Jul 2025550
9 Jul 20251340
10 Jul 2025360
8 Sept 202510
9 Sept 20251010
10 Sept 2025340
11 Sept 2025690
6 Oct 202520
7 Oct 202550
8 Oct 2025550
9 Oct 2025650
20 Oct 202530
21 Oct 2025130
22 Oct 20251860
23 Oct 2025550
13 Nov 20252670
24 Nov 202530
25 Nov 2025750
26 Nov 20251000
27 Nov 20251250
15 Dec 202540
16 Dec 2025660
17 Dec 2025430
18 Dec 2025420
20 Jan 2026670
21 Jan 20261120
22 Jan 2026580
9 Feb 202620
10 Feb 2026380
11 Feb 2026130
12 Feb 20261410
24 Feb 2026430
9 Mar 202610
10 Mar 20261970
11 Mar 2026600
12 Mar 2026340
25 Mar 202630
26 Mar 2026690
27 Apr 202620
28 Apr 20262250
29 Apr 20262960
30 Apr 2026680
18 May 202640
19 May 202630
20 May 2026960
21 May 2026980
15 Jun 202620
16 Jun 2026400
17 Jun 20261270
18 Jun 2026770
6 Jul 202620
7 Jul 2026720
8 Jul 20261440
9 Jul 2026670
14 Sept 202610
15 Sept 20261550
16 Sept 2026800
17 Sept 20261240

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within EPP

No member meets the rule within the group.

Outside the group

No member meets the rule outside the group.

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
BodyRoleFromTo
Delegation to the Parliamentary Assembly of the Union for the MediterraneanDMED Parliamentary assemblyChair3 Oct 2024now
Committee on the Environment, Public Health and Food SafetyENVI CommitteeMember19 Jul 202415 Sept 2024
Committee on Industry, Research and EnergyITRE CommitteeSubstitute19 Jul 20248 Sept 2024

Dossiers

Dossier: the procedure the declaration names (“No dossier named” for a delegation without one). Role: rapporteur, shadow rapporteur, negotiator or delegation. Committee: the committee that appointed them. Date: of the declaration.
DossierRoleCommitteeDate
EP delegation to the Conciliation Committee on Air Passenger Rights 2013/0072(COD)Trilogue negotiator18 Feb 2026

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

1 156 contributions recorded; 1 590 minutes of speaking time.

Date: the sitting. Debate: the item debated, and the group when they spoke on its behalf. Kind: speech or written statement, with speaking time. Verbatim: the verbatim report on Parliament’s site.
DateDebateKindVerbatim
17 Sept 2026Formal sitting – Address by Mark Carney, Prime Minister of Canada Speech · 3 minRead
16 Sept 2026State of the Union (debate) SpeechRead
16 Sept 2026State of the Union (debate) SpeechRead
16 Sept 2026State of the Union (debate) Speech · 3 minRead
14 Sept 2026Council positions at first reading (Rule 64) SpeechRead
14 Sept 2026Council positions at first reading (Rule 64) SpeechRead
14 Sept 2026Council positions at first reading (Rule 64) SpeechRead
14 Sept 2026Council positions at first reading (Rule 64) SpeechRead
14 Sept 2026Order of business Speech · 1 minRead
14 Sept 2026Order of business Speech · 1 minRead

Show all 40 recent contributions

Questions and motions, 0

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

No question or motion recorded this term.

Amendments tabled in committee, 0

Committee amendment documents that carry amendments by the member, with how many are theirs.

No committee amendment by this member found this term.

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political group

National delegation

  • Delegation Malta National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Data source
Licensed CC BY 4.0.
Data version
data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved
25 September 2026

Cite as

EU Parl Watch Research (2026). “Roberta METSOLA”. Member record. memberId 118859. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/118859?page=4&scope=all&vscope=all (retrieved 25 September 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/118859. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/118859?format=application%2Fld%2Bjson (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.
BibTeX
@misc{epw-member-118859,
  author = {{EU Parl Watch Research}},
  title = {{Roberta METSOLA}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/118859?page=4&scope=all&vscope=all}},
  url = {https://news.eu-parl.st-solutions.dev/members/118859?page=4&scope=all&vscope=all},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 118859. Official source: https://www.europarl.europa.eu/meps/en/118859. Data: EP Open Data: member record (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}